References
- Cheng H, Sutton SC, Pipkin JD, Zentner GM, Rogers JD, Schwartz JI et al. Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humans. Pharm Res 1993;10:1683–1687.
- McClelland GA, Stubbs RJ, Fix JA, Pogany SA, Zentner GM. Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. Pharm Res 1991;8:873–876.
- Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65–73.
- USP 24/NF 19, USP Convention. (2000). Rockville. pp1942.
- Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 1993;82:979–987.
- Burcham DL, Maurin MB, Hausner EA, Huang SM. Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharm Drug Dispos 1997;18:737–742.
- Serajuddin AT, Sheen PC, Mufson D, Bernstein DF, Augustine MA. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J Pharm Sci 1988;77:414–417.
- Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 1992;9:87–93.
- Craig DQM, Lievens HSR, Pitt KG, Storey DE. An investigation into the physicochemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int J Pharm 1993;96:147–155.
- Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994;106:15–23.
- Wakerly MG, Pouton CW, Meakin BJ, Morton FS. Self-emulsification of vegetable oil-nonionic surfactant mixtures: a proposed mechanism of action. ACS Symp Ser 1986;311:242–255.
- Kararli TT, Needham TE, Griffin M, Schoenhard G, Ferro LJ, Alcorn L. Oral delivery of a renin inhibitor compound using emulsion formulations. Pharm Res 1992;9:888–893.
- Myers RA, Stella VJ. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int J Pharm 1992;78:217–226.
- Palin KJ, Phillips AJ, Ning A. The oral absorption of cefoxitin from oil and emulsion vehicles in rats. Int J Pharm 1986;33:99–104.
- Stella V, Haslam J, Yata N, Okada H, Lindenbaum S, Higuchi T. Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. J Pharm Sci 1978;67:1375–1377.
- Toguchi H, Ogawa Y, Iga K, Yashiki T, Shimamoto T. Gastro-intestinal absorption of ethyl 2-chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate from different dosage forms in rats and dogs. Chem Pharm Bull 1990;38:2792–2796.
- Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997;25:103–128.
- Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 1999;16:461–521.
- Lieberman HA, Rieger MM, Banker GS, eds. (1996). Pharmaceutical dosage forms: Disperse systems. Second ed, Vol 1. New York: Marcel Decker, 211–281, 315–370.
- Kovarik JM, Mueller EA, van Bree JB, Tetzloff W, Kutz K. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 1994;83:444–446.
- Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ et al. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 2009;140:86–94.
- Kanga BK, Lee JS, Chona SK, Jeong SY, Yuk SH, Khanga G, Lee HB, Choc SH. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J of Pharm 2004;274:65–73.
- Patil P, Patil V, Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: in vitro and in vivo evaluation. Acta Pharm 2007;57:111–122.
- Spireas S, Sadu S, Grover R. In vitro release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci 1998;87:867–872.
- Staniforth JN. Pharmaceutics. (1988). In: Aulton ME ed The science of dosage form design. UK: Churchill, Livingstone, 610.
- Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm 2002;240:103–114.
- Sinko PJ ed (2006). Martin’s physical pharmacy and biopharmaceutical sciences. 5th ed. Philadelphia: Lippincott Williams &Wilkins, 558.
- Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle P. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm 2004;278:423–433.
- Chateau ME, Galet L, Soudais Y, Fages J. Processing a detergent powder formulation: direct compression, and high shear wet granulation followed by compression. Powder Technol 2005;157:191–198.
- British Pharmacopeia Commission. British Pharmacopeia. (2002). London: Her Majesty’s Stationary office.
- Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89–121.
- US Pharmacopeia Convention. (2002). United States Pharmacopeia. 3rd ed. Rockville: US Pharmacopeia Convention.
- Declaration of Helsinki. (2000). As amended by the 52nd World Medical Assembly (WMA). Edinburgh, Scotland: World Medical Association.
- FDA. (2002). Guidance of Industry, Food-effect Bioavailability and Bioequivalence Studies.
- Amy Y, Yang L, Donald S, Musson G, Jamie JZ. Short Application of a novel ultra-low elution volume 96-well solid-phase extraction method to the LC/MS/MS determination of simvastatin and simvastatin acid in human plasma. J Pharm Biomed Analysis 2005;38:521–527.
- Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur J Drug Metab Pharmacokinet 1991;16:249–255.
- Shukla JB, Patel SJ. Formulation and Evaluation of self micro emulsifying system of candesartan cilexetil. Int J Pharm and Pharmaceut Sci 2010;2:143–146.
- Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65–73.
- Dixit AR, Rajput SJ, Patel SG. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech 2010;11:314–321.
- Constantinides PP, Scalart JP, Lancaster C, Marcello J, Marks G, Ellens H et al. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res 1994;11:1385–1390.
- Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173–182.
- Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm 2007;57:315–332.
- Lu JL, Wang JC, Zhao SX, Liu XY, Zhao H, Zhang X et al. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice. Eur J Pharm Biopharm 2008;69:899–907.
- Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 2009;371:148–155.
- Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 2009;72:539–545.
- Nekkanti V, Karatgi P, Prabhu R, Pillai R. Solid self-microemulsifying formulation for candesartan cilexetil. AAPS PharmSciTech 2010;11:9–17.